ompany Name: Immuron Ltd
Immuron Ltd is a clinical stage biopharmaceutical company. The company is engaged in the development of immunomodulator polyclonal antibodies. The company’s pipeline includes product candidates for Non Alcoholic Steatohepatitis (NASH) and C. difficile.
Ticker Symbol: IMRN (NASDAQ)
Company Website: http://www.immuron.com
Social Media:
Headquarters: Armadale, Victoria, Australia